PAK1 and breast carcinoma: found that ivermectin inhibited the growth of breast cancer cells by promoting the ubiquitination degradation of PAK1, inhibiting the Akt/mTOR pathway, reducing autophagy levels, highlighting the growth-inhibitory effect of ivermectin on breast cancer cells (40).